Strides Shasun gets USFDA nod for dementia drug

Quoting IMS sales data, Strides Shasun said the US market for memantine hydrochloride tablets USP, 5mg and 10 mg is approximately USD 60 million.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news